Kevin Enzweiler
Publications by Year
Research Areas
Pneumonia and Respiratory Infections, Inflammatory mediators and NSAID effects, Estrogen and related hormone effects, Antibiotics Pharmacokinetics and Efficacy, Synthesis and Reactions of Organic Compounds
Most-Cited Works
- → New Cyclooxygenase-2/5-Lipoxygenase Inhibitors. 1. 7-tert-Butyl-2,3-dihydro-3,3-dimethylbenzofuran Derivatives as Gastrointestinal Safe Antiinflammatory and Analgesic Agents: Discovery and Variation of the 5-Keto Substituent(1998)53 cited
- → New Cyclooxygenase-2/5-Lipoxygenase Inhibitors. 3. 7-tert-Butyl-2,3-dihydro-3,3-dimethylbenzofuran Derivatives as Gastrointestinal Safe Antiinflammatory and Analgesic Agents: Variations at the 5 Position(1998)44 cited
- → New Cyclooxygenase-2/5-Lipoxygenase Inhibitors. 2. 7-tert-Butyl-2,3-dihydro-3,3-dimethylbenzofuran Derivatives as Gastrointestinal Safe Antiinflammatory and Analgesic Agents: Variations of the Dihydrobenzofuran Ring(1998)34 cited
- → Comparative activity of gatifloxacin and other antibiotics against 4009 clinical isolates of Streptococcus pneumoniae in the United States during 1999–2000(2002)17 cited
- → A Novel Method of Estimating Cost of Therapy by Using Patient Population Characteristics: Analysis of Fluoroquinolones in Various Populations with Different Distributions of Renal Function(2003)2 cited
- Assessment of the potential for city-wide antibiograms Differences in in vitro activity against Streptococcus pneumoniae within major metropolitan areas in the United States(2001)
- → PIN49 NEW ANTIFUNGAL MEDICATION IMPACT ON MARKET SHARE AND UTILIZATION OF TRADITIONAL AGENTS IN A SINGLE HEALTH CARE SYSTEM(2009)
- Analysis of Severe Blood Pressure Changes Involving IV Moxifloxacin at a Community Hospital(2004)